Melanotan II (Melanotan 2, MT-2) is a synthetic cyclic peptide and nonselective melanocortin receptor agonist — a structural analog of alpha-melanocyte-stimulating hormone (α-MSH) — studied in preclinical and in-vitro models of the melanocortin signaling system. It is sold strictly as a research-use-only (RUO) chemical. Melanotan II is not FDA-approved, is not a drug or dietary […]
MOTS-c is a 16-amino-acid mitochondrial-derived peptide (MDP) encoded within the mitochondrial 12S rRNA gene, studied in preclinical and in-vitro research for its role in mitochondrial signaling and metabolic regulation. It is sold strictly for research use only (RUO). The information below summarizes laboratory and animal findings and does not describe effects in humans. This product […]
PT-141 (bremelanotide) is a synthetic cyclic heptapeptide classified as a melanocortin receptor agonist, studied in clinical and preclinical research for its activity at melanocortin receptors in the central nervous system. Bremelanotide is also the active ingredient in an FDA-approved prescription medicine (Vyleesi). The material described here is sold strictly for laboratory research use only (RUO); […]
Tesamorelin is a synthetic growth hormone–releasing hormone (GHRH) analog studied in clinical and preclinical research for its effects on the growth hormone (GH) / insulin-like growth factor 1 (IGF-1) axis. The tesamorelin offered here is a research-use-only (RUO) material intended solely for laboratory investigation. It is not the FDA-approved prescription medicine and is not for […]
Cagrilintide is an investigational long-acting amylin analog used as a reference compound in laboratory metabolic research, where it is often studied alongside the GLP-1 analog semaglutide in a combination known as CagriSema. It is not an approved drug and has not been authorized by the FDA for any use. All products referenced here are sold […]
CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH) — specifically a modified hGRF(1–29) peptide — studied in laboratory and animal models as a long-acting growth-hormone secretagogue that activates the GHRH receptor on the anterior pituitary. This compound is offered strictly for research use only (RUO). It is not for human use, is not a […]
Glutathione (GSH) is a naturally occurring tripeptide — built from glutamate, cysteine, and glycine — that is widely studied in laboratories as a major intracellular antioxidant and as the central player in cellular redox (reduction–oxidation) balance. On this page it is described strictly as a research material. The information below summarizes preclinical and in-vitro findings […]
Retatrutide is an investigational triple GIP/GLP-1/glucagon receptor agonist — a single peptide engineered to bind three metabolic hormone receptors at once. It is currently in clinical trials and is not approved by the FDA for any use. Material offered here is sold strictly for research use only (RUO) and is not for human or veterinary […]
Semaglutide is a long-acting GLP-1 (glucagon-like peptide-1) receptor agonist that is widely studied in metabolic and incretin research. The material offered here is sold strictly as a research-use-only (RUO) reference compound — it is not for human or veterinary use, not for consumption, and is not an approved medicine in this form. Semaglutide is separately […]
Tirzepatide is a synthetic dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist studied in metabolic and incretin research. The same molecule is approved as a prescription medicine under the brand names Mounjaro and Zepbound, but the material described here is a research-use-only (RUO) reference compound — it is not that medicine, is […]
